Under construction – not a live service
Sign in
Taking people in DenmarkNo phase

A step-by-step care plan for depression treated by family doctors

Compares a structured treatment plan with usual care in adults with moderate depression.

Plain-language title generated from the registry record
Registry title: Improving Treatment for Depression in General Practice Using a Step-by-Step Care Plan.

Key facts

Where
Aalborg, DenmarkSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07263321, who can take part

Where in Denmark

  • Aalborg University Hospital, Department of PsychiatryAalborg, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Aalborg University Hospital
Trial code
NCT07263321
Record updated
10 December 2025
Original description
The goal of this clinical trial is to compare three different treatments for depression in patients with moderate depression in General Practice, aged 18-65 years.Read full original descriptionShow less

Optimising Treatment for Patients With Depressive Episodes in General Practice Through Algorithm-Based Treatment: A Randomised, Open-label Controlled Trial.

The goal of this clinical trial is to compare three different treatments for depression in patients with moderate depression in General Practice, aged 18-65 years.

We wish to investigate the effect of the treatment approaches, and 171 patients will be included in the trial. The participants will be randomised to one of the following three treatments:

1. Standard treatment provided by a general practitioner (i.e. the general practitioner treats the patient as he/she would normally do, when treating a patient with depression). 2. Standard treatment provided by a psychologist in the form behavioural therapy (i.e. the psychologist treats the patient as he/she would normally do, when treating a patient with depression). 3. A step-by-step treatment plan carried out by a general practitioner. The plan includes pre-determined follow-ups and a pre-determined, structured plan for which medications to use and when to increase dose or switch medication.

The hypothesis is that a structured and step-by-step treatment approach regarding patients with depression, treated in general practice, is more effective than standard treatment provided by a general practitioner and a psychologist.

All the participants will:

1. Receive one of the three treatments for 12 weeks. 2. Have meetings with the project staff every 4 weeks (week 0, 4, 8 and 12) were rating scales will be completed, e.g. a rating scale to measure progress or deterioration in the participant's depression.

Inclusion: The participant must be referred to the study with a diagnosis of unipolar depressive disorder, as judge by the GP; Severity of the depressive episode corresponding to moderate depression, as judged by the GP; Clinical uncertainty regarding which of the treatments, medication or psychotherapy, would be the better choice in the case concerned; Age criteria: Participants must be at least 18 years old and no more than 65 years old at the time of randomisation; The participant must be a patient in general practice; Participants must be able to participate in virtual meetings (e.g. by phone or computer) and have e-Boks; The participant must be willing to receive psychotherapy by a psychologist and/or medication; Must have signed the document of informed consent.

Exclusion: No current medical or psychotherapy treatment initiated within the last 4 weeks prior to screening; A diagnosis of dementia; Medical conditions that might interfere with the study outcome or safety, judged so by the investigator; Misuse of substances that might influence the study, as judged by the investigator; Difficulty in understanding the Danish language, as judged by the investigator; Pregnancy; High risk of non-adherence at the investigator's discretion; Suicidality: according to C-SSRS with a positive response to question 4 or 5 within the last three months or upon investigator's discretion.

ClinicalTrials.gov NCT07263321